Thymopoietin II (33-36) represents a minimal motif from a thymic regulatory peptide. Sequence composition favors turn formation and local structural ordering. Short length allows high-resolution conformational analysis by spectroscopic methods. Researchers use it to dissect microdomain contributions to thymopoietin signaling and receptor recognition.
CAT No: T07010
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More